NCT00639808View on ClinicalTrials.gov

Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

March 31, 2008

Conditions
GastroparesisDiabetes Mellitus
Interventions
DRUG

5% dextrose in water

60 ml IV infusion over 30 minutes

DRUG

TZP-101

1 infusion: IV 2ml/min for 30 minutes for 1 day of either 160, 320 or 600 micrograms/kg

Trial Locations (3)

Unknown

Aarhus Hospital, Aarhus

Hvidore Hospital, Copenhagen

Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Tranzyme, Inc.

INDUSTRY

NCT00639808 - Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis | Biotech Hunter | Biotech Hunter